"Elizabeth Whelan, president of the American Council on Science and Health, a public health advocacy group, disagrees."
Public health advocacy group my arse - more like "industry apologist group"! We know who funds that group, don't we? To contend that any level of exposure to poisons, and that is surely what unnatural industrial chemicals are, is safe is criminal!
But just to make sure ol' DQ is not just blowing steam without the facts, let's have a look at this "public health advocacy group" shall we?
One look at the first handful of articles on the home page pretty much tells it all:
Health Group Urges Reassessment of Asbestos as Human Health Risk
October 2007
Scientists and physicians associated with the American Council on Science and Health (ACSH) question whether typical asbestos exposures pose a substantial risk to human health. Although inhalation of high levels of asbestos fibers from occupational exposures has been linked to lung diseases, the effects of different types of fibers in non-occupational exposures is much less clear.
Danger from the "Superbugs" (from the Los Angeles Times) A Cancer Non-Epidemic (from the New York Post) Of Cascades and Diets (from the New York Times) Does Alcohol Cause Breast Cancer? (from HuffingtonPost.com) Booze & Breast Cancer (from the New York Post) Evista for Chemoprevention of Breast Cancer: Better Late Than Never, FDA (from MedicalProgressToday.com) Shots Now Fight Future Flu (from the New York Post) Drug Side Effects Up, But Benefits Up More (from HuffingtonPost.com) Be sure not to miss clicking on the booklike image on the left side of the home page for the report on how safe and wonderful irradiated foods are. At the webiste in "About ACSH" it says: ACSH was founded in 1978 by a group of scientists who had become concerned that many important public policies related to health and the environment did not have a sound scientific basis. These scientists created the organization to add reason and balance to debates about public health issues and bring common sense views to the public." But in the annual report it identifies Ms. Whelan as the founder. And, in the most recent form 990 we find that Ms. Whelan paid herself, I mean was paid a mere $286,288 to make such statements as the one quoted in the article in the above post and to author and serve up other "public advocacy" quotes in articles like the ones above and others on how safe mercury is, the need for flu shots, and other tripe about all the non-founded attacks on drug side effects, etc.
By Dr. Gilbert Ross. The alarming reports in the Journal of the American Medical Association outlining the extent of two "superbug" infections should chasten those who call for ever-more-stringent regulation of pharmaceutical companies and their products
By Jeff Stier. We have an epidemic of disbelief about cancer in this country -- but it's the opposite of what you probably expect. Cancer death rates have been falling for years, and now are falling even faster. Yet it's still stories about allegedly ignored cancer threats that grab our attention
By Dr. Ruth Kava. John Tierney rightfully decries the "cascade effect," the tendency of health experts (like most people) to echo the opinions of their peers, even if they aren’t completely familiar with the literature in question
By Dr. Elizabeth Whelan. After last week's mega-coverage of the reported association of breast cancer and alcohol consumption, we at ACSH received many queries -- some from very nervous women. Was the answer to follow an alcohol abstention program? After all, the news reports repeatedly said "any amount" of alcohol of "any type" -- beer, wine, or spirits -- upped breast cancer risk. What is a woman to do
By Dr. Elizabeth Whelan. The news Friday suggesting that even a glass or two of wine a day will leave women at risk of breast cancer is, well, sobering. Does this mean that women, young and old, invite disaster if they participate in happy hour? No: The headlines not only overhype the danger, they omit a reliable countermeasure
By Gilbert L. Ross. An aphorism never truer: when discussing breast cancer, an ounce of prevention is better for public health than the cures currently available, and much cheaper. So, after a long–and–winding eight–year period of data accumulation, we should applaud the FDA for finally approving Lilly's "designer estrogen," Evista (raloxifene), for use in postmenopausal high–risk women to lower their risk of invasive breast cancer. But we should question why the FDA took this long in the first place
By Dr. Elizabeth Whelan. It's flu-shot season again. The good news is that we've got plenty of vaccine this year; the bad news is that far too many Americans will skip their shots. One health problem is that even high-risk people have been skipping in recent years. Another is that shots that go to waste endanger the nation's future supply of vaccine
By Jeff Stier. The news of a marked increase in adverse drug events reported to the FDA is sure to be one more arrow for those taking aim at "big pharma" and the FDA. The criticism is off target, however, because it fails to take into account the new ways drugs are being used...
Oh yeah, she also received another $25,989 paid into her pension fund and all her expenses were paid as well. Nowhere does it say who the donors are, or what government agencie might have issued grants. It does show a couple of stock sales. One of them was stock in some company named Pfizer. And $65,000 and change in interest earnings was reported for the year, so there must be a tidy sum tucked away somewhere.
Not a bad gig if you can create it. More than a few pieces of silver, but the same end result I would say.
DQ